Skip to main content
Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
2.080
-0.050 (-2.35%)
At close: Apr 28, 2026, 4:00 PM EDT
2.080
0.00 (0.00%)
Pre-market: Apr 29, 2026, 8:43 AM EDT

Caribou Biosciences Revenue

In the year 2025, Caribou Biosciences had annual revenue of $11.16M with 11.66% growth. Caribou Biosciences had revenue of $3.94M in the quarter ending December 31, 2025, with 89.74% growth.

Revenue (ttm)
$11.16M
Revenue Growth
+11.66%
P/S Ratio
18.01
Revenue / Employee
$115,041
Employees
97
Market Cap
201.01M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202511.16M1.17M11.66%
Dec 31, 20249.99M-24.48M-71.01%
Dec 31, 202334.48M20.63M148.91%
Dec 31, 202213.85M4.25M44.31%
Dec 31, 20219.60M-2.76M-22.35%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MacroGenics 149.50M
Karyopharm Therapeutics 146.07M
OmniAb 18.67M
MediWound 16.96M
Whitehawk Therapeutics 7.15M
Revenue Rankings

CRBU News

More News